Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. K. (Karina) Meijer


Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants

Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism

Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients

De combinatiepil is geen goede keuze (meer) voor 35-plussers

Effect of previous INR control during VKA therapy on subsequent DOAC adherence and persistence, in patients switched from VKA to DOAC

Ethical aspects of hemophilia gene therapy: a qualitative interview study with stakeholders

Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression

Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Read more


Na je 40e vergroot de anticonceptiepil de kans op trombose

Zorgen over anticonceptiepil na 35ste

Dit wil je weten over de bijwerkingen van bloedverdunners

Gentherapie als wapen tegen hemofilie B

Drie patiënten genezen van hemofilie B na onderzoek in UMCG

Hoop voor hemofilie B patiënten door nieuwe gentherapie

NVHP webinars terugkijken

Kijk terug: webinar gentherapie en webinar Hemofilie in Nederland

Read more